JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Universal Health Services
UHS
$10.5B
| $222M | 0.05% |
1,957,266
+94,243
| +5% | +$10.1M |
|
402
MPLX
MPLX
$59.7B
| $222M | 0.05% |
6,254,216
+471,027
| +8% | +$16.6M |
|
403
Micron Technology
MU
$991B
| $221M | 0.05% |
5,381,111
-7,928,737
| -60% | -$342M |
|
404
Park Hotels & Resorts
PK
$2.97B
| $220M | 0.05% |
7,648,997
+1,141,116
| +18% | +$32.7M |
|
405
Marriott International
MAR
$92.3B
| $219M | 0.05% |
1,610,570
+213,756
| +15% | +$26.2M |
|
|
Y
406
DELISTED
Alleghany Corp
Y
| $218M | 0.05% |
365,343
+11,356
| +3% | +$6.48M |
|
407
Ecolab
ECL
$79.9B
| $217M | 0.05% |
1,617,341
-42,271
| -3% | -$5.62M |
|
408
Regions Financial
RF
$26.8B
| $211M | 0.04% |
12,231,584
-5,381,195
| -31% | -$86M |
|
409
HCA Healthcare
HCA
$89.5B
| $211M | 0.04% |
2,396,603
-188,375
| -7% | -$15.1M |
|
410
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $210M | 0.04% |
4,674,861
-10,693,333
| -70% | -$472M |
|
411
PUT
Microsoft
MSFT
$3.71T
| $210M | 0.04% |
2,451,500
+904,100
| +58% | +$74.2M |
|
412
Portland General Electric
POR
$5.77B
| $210M | 0.04% |
4,597,180
+46,883
| +1% | +$2.22M |
|
413
Copart
CPRT
$27.5B
| $209M | 0.04% |
19,345,780
+940,924
| +5% | +$9.16M |
|
414
Gildan
GIL
$10.6B
| $208M | 0.04% |
6,450,939
+2,537,674
| +65% | +$79.2M |
|
415
Plains All American Pipeline
PAA
$16.1B
| $207M | 0.04% |
10,040,158
+550,364
| +6% | +$11.2M |
|
416
Incyte
INCY
$24.4B
| $206M | 0.04% |
2,175,873
+73,526
| +3% | +$7.69M |
|
417
Jazz Pharmaceuticals
JAZZ
$16.7B
| $204M | 0.04% |
1,515,597
-157,136
| -9% | -$21.8M |
|
418
PUT
Netflix
NFLX
$309B
| $202M | 0.04% |
10,548,000
+313,000
| +3% | +$6.03M |
|
419
Cincinnati Financial
CINF
$27.1B
| $202M | 0.04% |
2,700,784
-60,160
| -2% | -$4.48M |
|
420
CALL
Meta Platforms (Facebook)
META
$1.51T
| $201M | 0.04% |
1,140,800
-317,000
| -22% | -$56M |
|
421
American Homes 4 Rent
AMH
$12.5B
| $201M | 0.04% |
9,209,765
-34,267
| -0.4% | -$744K |
|
422
Edgewell Personal Care
EPC
$1.31B
| $199M | 0.04% |
3,353,507
-122,947
| -4% | -$7.74M |
|
423
Realty Income
O
$59.1B
| $199M | 0.04% |
3,594,617
-984,224
| -21% | -$53.4M |
|
424
Yum China
YUMC
$16.3B
| $198M | 0.04% |
4,935,944
-962,304
| -16% | -$39.6M |
|
425
Equity Lifestyle Properties
ELS
$12.6B
| $197M | 0.04% |
4,429,678
+2,152,798
| +95% | +$95.8M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.